Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study

[1]  A. Hyland,et al.  Longitudinal Uses of the Population Assessment of Tobacco and Health Study. , 2021, Tobacco regulatory science.

[2]  E. Benjamin,et al.  Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018 , 2020, JAMA network open.

[3]  P. Caponnetto,et al.  COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up , 2020, Therapeutic advances in chronic disease.

[4]  I. Rahman,et al.  Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): Results from the Population Assessment of Tobacco and Health (PATH) study, Wave 4 , 2020, Tobacco induced diseases.

[5]  R. Pleasants,et al.  Both Duration and Pack-years of Tobacco Smoking Should be Used for Clinical Practice and Research. , 2020, Annals of the American Thoracic Society.

[6]  A. Hyland,et al.  Longitudinal pathways of exclusive and polytobacco cigarette use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016) , 2020, Tobacco Control.

[7]  A. Hyland,et al.  Longitudinal pathways of exclusive and polytobacco cigar use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016) , 2020, Tobacco Control.

[8]  H. Gouda,et al.  Lung health, tobacco, and related products: gaps, challenges, new threats, and suggested research , 2020, American journal of physiology. Lung cellular and molecular physiology.

[9]  Jun Yu Li,et al.  Correlation between biomarkers of exposure, effect and potential harm in the urine of electronic cigarette users , 2020, BMJ Open Respiratory Research.

[10]  Michael E. Hall,et al.  Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017. , 2019, American journal of preventive medicine.

[11]  J. Freudenheim,et al.  Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[12]  I. Rahman,et al.  Use of electronic cigarettes and self-reported COPD diagnosis in adults. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  I. Rahman,et al.  Use of electronic cigarettes and self-reported COPD diagnosis in adults. , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  S. Glantz,et al.  Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. , 2019, American journal of preventive medicine.

[15]  Mei Han,et al.  The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients , 2019, Medicine.

[16]  N. Atuegwu,et al.  Adult E-Cigarettes Use Associated with a Self-Reported Diagnosis of COPD , 2019, International journal of environmental research and public health.

[17]  J. Mazurek,et al.  Chronic Obstructive Pulmonary Disease Prevalence Among Adults Who Have Never Smoked, by Industry and Occupation — United States, 2013–2017 , 2019, MMWR. Morbidity and mortality weekly report.

[18]  O. Kurmi,et al.  Under- and over-diagnosis of COPD: a global perspective , 2019, Breathe.

[19]  I. Adcock,et al.  Heightened response to e-cigarettes in COPD , 2019, ERJ Open Research.

[20]  Katie Myers Smith,et al.  A Randomized Trial of E‐Cigarettes versus Nicotine‐Replacement Therapy , 2019, The New England journal of medicine.

[21]  T. Wills,et al.  E-cigarette use and respiratory disorder in an adult sample. , 2019, Drug and alcohol dependence.

[22]  L. Boulet,et al.  Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease , 2018, American journal of respiratory and critical care medicine.

[23]  R. Tourangeau,et al.  Population Assessment of Tobacco and Health (PATH) reliability and validity study: selected reliability and validity estimates , 2018, Tobacco Control.

[24]  Timothy Tilert,et al.  Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012. , 2018, EC pulmonology and respiratory medicine.

[25]  M. Caruso,et al.  Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up , 2018, International journal of chronic obstructive pulmonary disease.

[26]  P. Austin,et al.  Marijuana Use, Respiratory Symptoms, and Pulmonary Function , 2018, Annals of Internal Medicine.

[27]  W. Goessler,et al.  Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils , 2018, Environmental health perspectives.

[28]  K. Cummings,et al.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study , 2016, Tobacco Control.

[29]  T. To,et al.  Factors associated with undiagnosed and overdiagnosed COPD , 2016, European Respiratory Journal.

[30]  E. Regan,et al.  A Simplified Score to Quantify Comorbidity in COPD , 2014, PloS one.

[31]  Timothy Tilert,et al.  Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010 , 2013, Respiratory Research.

[32]  R. Polosa,et al.  A fresh look at tobacco harm reduction: the case for the electronic cigarette , 2013, Harm Reduction Journal.

[33]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[34]  P. Lee,et al.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema , 2011, BMC pulmonary medicine.

[35]  D. Mannino,et al.  COPD in Never Smokers , 2011, Chest.

[36]  J. Walusiak‐Skorupa,et al.  Faculty Opinions recommendation of COPD in never smokers: results from the population-based burden of obstructive lung disease study. , 2011 .

[37]  J. Stockman.  The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction: A Cross-sectional Study , 2011 .

[38]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[39]  R. Barr,et al.  The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction , 2010, Annals of Internal Medicine.

[40]  S. Sidney,et al.  The impact of SHS exposure on health status and exacerbations among patients with COPD , 2009, International journal of chronic obstructive pulmonary disease.

[41]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[42]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[43]  James L. Repace,et al.  Health risks associated with cigar smoking. , 2000, JAMA.

[44]  C. Iribarren,et al.  Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. , 1999, The New England journal of medicine.

[45]  P. J. McCarthy.  Pseudoreplication: further evaluation and applications of the balanced half-sample technique. , 1969, Vital and health statistics. Series 2, Data evaluation and methods research.